Literature DB >> 8475552

Renal transplantation following immunoadsorption in highly sensitized recipients.

C N Ross1, G Gaskin, S Gregor-Macgregor, A A Patel, N J Davey, R I Lechler, G Williams, A J Rees, C D Pusey.   

Abstract

Five highly sensitized patients, with panel reactivity greater than 80% for 1.75-5 years, were treated by extracorporeal staphylococcal protein-A immunoadsorption, prednisolone, and cyclophosphamide. The five patients underwent treatment of 18-40 (mean 31) liters of plasma, respectively in 4-7 (mean 5.6) sessions. This reduced the titer of cytotoxic antibodies to sensitizing antigens to < 1/8 in all cases and abolished reactivity to crossreacting antigens. Two patients required retreatment following resynthesis of cytotoxic antibodies. All five patients have been transplanted, and four of these now have stable serum creatinines of 168 mumol/L at 34 months, 208 mumol/L at 29 months, 96 mumol/L at 5 months, and 125 mumol/L at 3 months posttransplantation. One patient had primary graft dysfunction due to acute tubular necrosis; the kidney was removed after eight weeks and showed cortical necrosis without evidence of acute rejection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475552     DOI: 10.1097/00007890-199304000-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model.

Authors:  Naohiko Fukami; Sabarinathan Ramachandran; Kishore Narayanan; Wei Liu; Dilip S Nath; Martin Jendrisak; William Chapman; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

2.  Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

Authors:  Hong Xu; Paula M Chilton; Michael K Tanner; Yiming Huang; Carrie L Schanie; Mariano Dy-Liacco; Jun Yan; Suzanne T Ildstad
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

3.  Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients.

Authors:  Patricia A Taylor; Michael J Ehrhardt; Matthew M Roforth; Jessica M Swedin; Angela Panoskaltsis-Mortari; Jonathan S Serody; Bruce R Blazar
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

4.  C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Authors:  Mark Haas; Dorry L Segev; Lorraine C Racusen; Serena M Bagnasco; Jayme E Locke; Daniel S Warren; Christopher E Simpkins; Diane Lepley; Karen E King; Edward S Kraus; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

Review 5.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 6.  B cells in transplant tolerance and rejection: friends or foes?

Authors:  Robin Schmitz; Zachary W Fitch; Paul M Schroder; Ashley Y Choi; Annette M Jackson; Stuart J Knechtle; Jean Kwun
Journal:  Transpl Int       Date:  2020-01       Impact factor: 3.782

7.  Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients.

Authors:  Monal Sharma; S A Webber; A Zeevi; T Mohanakumar
Journal:  Hum Immunol       Date:  2019-01-30       Impact factor: 2.850

Review 8.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 9.  Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Edward J Filippone
Journal:  Vaccines (Basel)       Date:  2021-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.